List of Genetic Analysis/Screening Companies in Italy - 5

Driven by our mission to advance research and improve lives, BMR Genomics serves as a trusted partner for both academic and commercial projects in the life sciences. BMR Genomics, a spin-off of the University of Padua, initially focused on providing DNA analysis to universities and research centers. BMR has grown into a leading provider of comprehensive genomics services for researchers, companies, and private individuals across the life sciences sector. In 2008, we were honored with the award for Italy's best start-up. At BMR Genomics, we offer a broad range of advanced services, including DNA sequencing (Sanger, Illumina, and Oxford Nanopore), cell authentication (Cell Profile), DNA genotyping, and bioinformatics support. Additionally, we supply life science lab products through Easy Shop and custom oligonucleotides through Custom Primer. We also cater to private individuals and professionals by providing human identification, paternity, and relative testing. Our expertise spans diverse areas such as medical diagnostics, microbiology, agriculture, veterinary science, and environmental research. With cutting-edge laboratories and a commitment to staying at the forefront of genomics and bioinformatics, we continually innovate to meet the evolving needs of the scientific community. For more information, contact us at commerciale@bmr-genomics.it.

We offer whole genome sequencing to help you understand your health, lifestyle, and the risk of inheriting diseases. Simple, clear, and personal reports.

Diatech Pharmacogenetics, the leading Italian Precision Medicine company. Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting. The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding. Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions to extract nucleic acids from patient samples, analyse them with the most advanced technologies and interpret them with the latest bioinformatic algorithms. Excellence in each step of the diagnostic pipeline results in the personalisation of treatments, increased drug efficacy, reduced side-effects and ultimately better patient outcomes.

Ulisse BioMed is a healthcare biotech company operating in diagnostics, theranostics and therapeutics with the mission to develop innovative solutions in these fields. Ulisse BioMed has three proprietary technology platforms capable of generating innovative and competitive products: Sagitta (molecular diagnostics), NanoHybrid (theranostics and diagnostics) and Aptavir (therapeutics). Ulisse BioMed owns a portfolio of intellectual properties made of 8 international patent applications that cover the three technology platforms (3 related to Sagitta, 2 related to NanoHybrid, 1 related to Aptavir and 2 transversal to the three platforms), two of them are granted in Italy and in Europe.

Zambon is a modern healthcare company founded on the history and values of an Italian family and committed to innovating cure & care to improve patients’ lives. Zambon is present in three different Continents – Europe, America and Asia – with manufacturing units in Italy, Switzerland, France, China and Brazil. Zambon SpA, the pharma subsidiary of the group with its 23 branches, has taken a new role in the industry. In addition to pain and diseases of the respiratory system and urological system, Zambon is establishing a global pipeline and introducing important treatments for serious diseases such as Parkinson’s Disease, Cystic Fibrosis, BOS and NCFB. In recent years, ZBiotech, a specialized biotech company that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through through the scouting, acquisition, licensing and development of new molecules, has also been established. Zambon produces high quality products thanks to the management of the whole production chain which involves Zach-Zambon Chemicals, a privileged partner for API, custom synthesis and generic products. Zambon complements the offering of medicines with modern health solutions, in order to translate its Vision into concrete actions. Zcube - Zambon Research Venture - is actively scouting for modern health solutions in the field of drug delivery systems, medical devices, biomarkers, diagnostics, digital health and big data solutions. In 2018 Zcube established Careapt, a new start-up which develops integrated Hi-Tech/Hi-Touch solutions for chronic disease management. The group also includes ItaliAssistenza, a Home Care Company involved in Patient Support Programs and home care. Zambon was established in 1906 in Vicenza and is headquartered in Milan within OpenZone, the scientific campus where knowledge is shared between partners in the field of Healthcare, founded with the aim to transform research into enterprise.